Regulatory
-
Apr 15 2026MSN Labs Disrupts Diabetes Care with SEMABEST: India’s First Fully Integrated Semaglutide Follows Patent Expiry
From API to Pen: MSN Laboratories Challenges Global Giants with…
Read more -
Apr 04 2026Trump’s Tariff Gambit: Pharma & Metals in the Crossfire of Global Trade
Executive Orders That Redefine Trade Boundaries US President Donald Trump…
Read more -
Apr 01 2026Vyome Delivers Breakthrough 2025 Performance, Sets Stage for Next Growth Chapter
Vyome is building the world’s premier platform spanning the US-India…
Read more -
Feb 09 2026India–US Trade Deal Secures Lifeline for Affordable Generics – Dr Dilip Surana
Dr Dilip Surana, CMD of Micro Labs Limited, hails tariff…
Read more -
Sep 07 2025Taxing the Thirsty: When the Middle Class Funds the Billionaire’s Champagne
In a nation where economic inequality is widening, a startling…
Read more -
Aug 02 2024AiMeD hails Union Budget-2024; will give a boost to overall economic growth: Rajiv Nath
The Association of Indian Medical Device Industry (AiMeD) on Tuesday…
Read more -
Jul 11 2023280 Bio gets US FDA approval to begin phase 1 trial of novel KRAS inhibitor, YL-17231
280Bio, Inc. a clinical stage biotechnology company focused on the…
Read more -
Apr 14 2023Dr Kannan Vishwanatth, Royal Society of Chemistry fellow develop Breakthrough Innovations in Cancer Treatment.
Rupus Global Founder Dr Kannan Vishwanatth has made Breakthrough in…
Read more -
Jul 12 2022MTaI urges the Government not to levy TDS on free medical samples to Doctors and Clinicians
Requests reconsideration of TDS provisions on reimbursement of out-of-pocket expenses…
Read more -
Jun 06 2020Novartis phase IIIb ARGON study meets primary endpoint in a comparison of Enerzair Breezhaler vs free combo of two existing inhaled treatments in uncontrolled asthma
Novartis announced that full results from the phase IIIb ARGON…
Read more
